Trial intelligence / Profile preview

Safety and Efficacy of COVIDEX in Adult COVID-19 Patients

NCT05228626Phase 2Unknown

Sponsor
Makerere University
Start
Mar 2022
Primary completion
Nov 2022
Modality
HM (Herbal Medicine)
Countries
1
01

Overview

A Phase 2 trial of COVIDEX in coronavirus disease 2019 (COVID-19), sponsored by Makerere University. Status: unknown.

02

Drugs

COVIDEX
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT05228626.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05228626.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call